An Observational Study on the Impact of the 23-valent Pneumonia Vaccine on Lung Cancer Patients

NCT07142057 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

LUNG CANCER

Interventions

BIOLOGICAL: 23-valent pneumococcal vaccine

Sponsor

The First Affiliated Hospital of Guangzhou Medical University